The Protein Brewery says FDA GRAS setback won’t derail US plans as it raises $20.5m Series B extension

The Protein Brewery was advised by the FDA to withdraw and refile its GRAS notice due to “deficiencies” but insists the move won't derail its US plans. The post The Protein Brewery says FDA GRAS setback won’t derail US plans as it raises $20.5m Series B extension appeared first on AgFunderNews.

CryptoAlerta — análise de criptomoedas e mercado em tempo real